Aemetis, Inc. (NASDAQ:AMTX) Sees Large Growth in Short Interest

Aemetis, Inc. (NASDAQ:AMTX) was the recipient of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 5,320,000 shares, an increase of 14.7% from the March 15th total of 4,640,000 shares. Based on an average trading volume of 1,220,000 shares, the days-to-cover ratio is currently 4.4 days.

Hedge Funds Weigh In On Aemetis

Several hedge funds have recently made changes to their positions in the business. Charles Schwab Investment Management Inc. grew its stake in shares of Aemetis by 3.1% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 75,306 shares of the specialty chemicals company’s stock worth $955,000 after acquiring an additional 2,254 shares in the last quarter. JPMorgan Chase & Co. grew its stake in shares of Aemetis by 16.0% during the 1st quarter. JPMorgan Chase & Co. now owns 16,362 shares of the specialty chemicals company’s stock worth $208,000 after acquiring an additional 2,256 shares in the last quarter. Guggenheim Capital LLC grew its stake in shares of Aemetis by 18.7% during the 3rd quarter. Guggenheim Capital LLC now owns 17,879 shares of the specialty chemicals company’s stock worth $110,000 after acquiring an additional 2,818 shares in the last quarter. Point72 Asset Management L.P. bought a new position in shares of Aemetis during the 2nd quarter worth approximately $25,000. Finally, Tower Research Capital LLC TRC grew its stake in shares of Aemetis by 173.7% during the 3rd quarter. Tower Research Capital LLC TRC now owns 5,586 shares of the specialty chemicals company’s stock worth $34,000 after acquiring an additional 3,545 shares in the last quarter. 27.02% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

AMTX has been the topic of a number of research analyst reports. Stifel Nicolaus decreased their price objective on shares of Aemetis from $8.00 to $6.50 and set a “buy” rating on the stock in a report on Wednesday, February 21st. Truist Financial cut their price target on shares of Aemetis from $5.00 to $3.50 and set a “hold” rating on the stock in a research report on Tuesday, January 23rd.

Aemetis Stock Performance

AMTX stock traded down $0.05 during mid-day trading on Tuesday, hitting $4.03. 377,998 shares of the company were exchanged, compared to its average volume of 1,157,258. The firm’s 50 day simple moving average is $4.08 and its 200 day simple moving average is $4.34. Aemetis has a 1-year low of $1.16 and a 1-year high of $8.99.

Aemetis (NASDAQ:AMTX) last announced its earnings results on Thursday, March 7th. The specialty chemicals company reported ($0.34) EPS for the quarter, topping the consensus estimate of ($0.35) by $0.01. The company had revenue of $70.76 million for the quarter, compared to analyst estimates of $80.08 million. During the same quarter last year, the business posted ($0.63) earnings per share. On average, analysts expect that Aemetis will post -1.44 earnings per share for the current fiscal year.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.